Tiragolumab and Atezolizumab in Advanced Pan-cancer Patients
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-08-22
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- Omico
- Target Recruit Count
- 96
- Registration Number
- NCT06003621
- Locations
- 🇦🇺
Border Medical Oncology Research Unit, Albury, New South Wales, Australia
🇦🇺Ramsay Health Care Australia Pty Ltd trading as The Border Cancer Hospital, Albury, New South Wales, Australia
🇦🇺Coffs Harbour Health Campus, Coffs Harbour, New South Wales, Australia
© Copyright 2024. All Rights Reserved by MedPath